NewsRx

Search our medical news database

Hepatitis A Vaccines

Company Patents Sleeper Vaccine Technology

Published in Vaccine Weekly, April 21st, 1997

DynaGen, Inc., Cambridge, Massachusetts, announced that the U.S. Patent and Trademark Office has issued a notice of allowance for the Sleeper vaccine technology.

The work had previously been funded by the U.S. Army Medical Research and Development Command under an SBIR contract to further develop the technology for the delivery of hepatitis A vaccine.

According to the World Health Organization (WHO), the 1995 global vaccine market was estimated at $3 billion. A major issue with current vaccine technology continues to be the need for vaccines that deliver all of the required components in a single administration rather than a format that requires...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook